 AcelRx Pharmaceuticals Inc NASDAQ: ACRX has agreed to provide a license to Laboratoire Aguettant to commercialize Dzuveo in Europe and give AcelRx two prefilled syringe product candidates for the U.S. Under the Dzuveo licensing agreement, Aguettant will have the right to commercialize Dzuveo in Europe. 